eli lilly glp 1 Administration Anounces Landmark GLP-1 Pricing Agreement with and Novo Nordisk Lilly is selling $12.9 billion
Description
Scientists have now created long-lasting GLP-1 drugs that can be used to treat type 2 diabetes, obesity, and a range of other conditions
Read the article to know more.
We hope that this tool helps patients with the information they need to start their health journey with GLP-1s.
FDA approval is anticipated in 2026, through the FDA's national priority voucher program, positioning Lilly to compete aggressively in the oral segment
